Whereas PLA2G6 is known to be a proinflammatory mediator required for monocyte chemotaxis and potentially contributory to both atherosclerosis and diabetes,[82] the link between both PLAG4B & PLB1 and obesity, diabetes, or cardiovascular diseases is currently unknown. Here, PLA2G6 is linked to atherosclerosis.